Selective Arterial Embolization of Pseudoaneurysms and Arteriovenous Fistulas after Partial Nephrectomy: Safety, Efficacy, and Mid-Term Outcomes.
arteriovenous fistula
bleeding
embolization
interventional radiology
kidney tumor
partial nephrectomy
pseudoaneurysm
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
07 Jul 2023
07 Jul 2023
Historique:
received:
16
06
2023
revised:
01
07
2023
accepted:
04
07
2023
medline:
29
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
The primary objective was to evaluate the clinical success rate after endovascular embolization of iatrogenic vascular lesions caused during partial nephrectomy. The secondary objective was to evaluate the technical success and to assess potential effects on renal function. We retrospectively included consecutive patients from our center who underwent selective embolization to treat iatrogenic renal arterial lesions induced during partial nephrectomy between June 2010 and June 2020. The technical and clinical success rates and renal outcomes were collected. We identified 25 patients with 47 pseudoaneurysms and nine arteriovenous fistulas. Among them, eight were treated by coils only, eight by liquid embolization agents only, and nine by both. The technical success rate was 96% after the first attempt and 100% after the second attempt. The median follow-up was 27.1 ± 24.3 months. Clinical success, defined as no need for further hemostatic surgery during follow-up, was also obtained in 96% and 100% of patients with one and two attempts, respectively. Renal function estimated by the modification of diet in renal disease equation did not change significantly despite a mean 13.8% ± 15.1% decrease in kidney functional volume estimated by angiography. No complications were attributable to the endovascular treatment. No significant difference was found across embolization agents; however, the subgroup sizes were small. Endovascular embolization is safe and effective for treating iatrogenic arterial lesions after partial nephrectomy: success rates are high, complications are infrequent, and renal function is maintained. Recommendations by interventional radiology societies are needed to standardize this treatment.
Identifiants
pubmed: 37509574
pii: biomedicines11071935
doi: 10.3390/biomedicines11071935
pmc: PMC10377731
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Tech Vasc Interv Radiol. 2007 Dec;10(4):299-307
pubmed: 18572145
Rofo. 2016 Feb;188(2):188-94
pubmed: 26756934
J Urol. 2005 Dec;174(6):2256-9
pubmed: 16280793
Urology. 2011 Oct;78(4):820-6
pubmed: 21813164
Prog Urol. 2018 Mar;28(3):146-155
pubmed: 29331568
Urology. 2009 Oct;74(4):819-23
pubmed: 19647302
Diagn Interv Imaging. 2014 Jun;95(6):601-9
pubmed: 24637204
J Urol. 2006 Dec;176(6 Pt 1):2353-8
pubmed: 17085101
J Urol. 2004 Mar;171(3):1066-70
pubmed: 14767272
J Urol. 2008 Feb;179(2):468-71; discussion 472-3
pubmed: 18076931
J Endourol. 2010 Jan;24(1):149-54
pubmed: 19954351
Radiol Med. 2014 Apr;119(4):261-8
pubmed: 24297586
Am J Kidney Dis. 2002 Feb;39(2 Suppl 1):S1-266
pubmed: 11904577
Prog Urol. 2018 Nov;28 Suppl 1:R5-R33
pubmed: 31610874
Prog Urol. 2015 Jan;25(1):18-21
pubmed: 25450752
Diagn Interv Radiol. 2015 May-Jun;21(3):229-34
pubmed: 25835080
Urology. 2001 Jul;58(1):105
pubmed: 11445492
J Urol. 2004 Jan;171(1):130-4
pubmed: 14665860
J Urol. 2011 Aug;186(2):405-10
pubmed: 21680004
J Urol. 2013 May;189(5):1643-8
pubmed: 23219544
Clin Chem. 2007 Apr;53(4):766-72
pubmed: 17332152
J Vasc Interv Radiol. 2006 Sep;17(9):1383-97; quiz 1398
pubmed: 16990459
J Endourol. 2013 Dec;27(12):1516-9
pubmed: 24199730
Clin Hemorheol Microcirc. 2010;46(2-3):127-37
pubmed: 21135488
Eur Radiol. 2015 Apr;25(4):1140-7
pubmed: 25537978
Eur Urol. 2012 Dec;62(6):1097-117
pubmed: 22841673
J Am Coll Cardiol. 2007 Aug 14;50(7):584-90
pubmed: 17692741
Clin Radiol. 2007 Nov;62(11):1104-9
pubmed: 17920871
Kidney Int Suppl. 2006 Apr;(100):S51-3
pubmed: 16612402
Semin Intervent Radiol. 2014 Mar;31(1):104-6
pubmed: 24596448
Lancet Oncol. 2006 Sep;7(9):735-40
pubmed: 16945768
J Urol. 2011 Jun;185(6):2061-5
pubmed: 21496835
CA Cancer J Clin. 2008 Mar-Apr;58(2):71-96
pubmed: 18287387
Urology. 2003 Aug;62(2):227-31
pubmed: 12893324
Cardiovasc Intervent Radiol. 2007 Sep-Oct;30(5):828-32
pubmed: 17508241
World J Urol. 2010 Aug;28(4):519-24
pubmed: 20563584
Eur Urol. 2007 Jul;52(1):148-54
pubmed: 17240036
Urology. 2020 Jul;141:108-113
pubmed: 32283170
Korean J Urol. 2014 Jan;55(1):17-22
pubmed: 24466392